Design Therapeutics
DSGN
DSGN
95 hedge funds and large institutions have $108M invested in Design Therapeutics in 2024 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 36 increasing their positions, 27 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
13% less capital invested
Capital invested by funds: $124M → $108M (-$16.4M)
93% less call options, than puts
Call options by funds: $5K | Put options by funds: $75K
Holders
95
Holding in Top 10
1
Calls
$5K
Puts
$75K
Top Buyers
| 1 | +$4M | |
| 2 | +$1.33M | |
| 3 | +$761K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$601K |
| 5 |
Millennium Management
New York
|
+$423K |
Top Sellers
| 1 | -$1.91M | |
| 2 | -$1.53M | |
| 3 | -$517K | |
| 4 |
Walleye Capital
New York
|
-$450K |
| 5 |
Morgan Stanley
New York
|
-$297K |